71
Participants
Start Date
September 13, 2018
Primary Completion Date
March 12, 2020
Study Completion Date
March 12, 2020
40 mg Rifaximin SSD once daily
SSD once daily (QD)
40 mg Rifaximin SSD twice daily
SSD twice daily (BID)
80 mg Rifaximin SSD once daily
SSD once daily (QD)
80 mg Rifaximin SSD twice daily
SSD twice daily (BID)
Placebo
Administered twice daily (BID)
Bausch Health Site 09, New York
Bausch Health Site 28, New York
Bausch Health Site 36, Brooklyn
Bausch Health Site 12, Pittsburgh
Bausch Health Site 11, Philadelphia
Bausch Health Site 26, Philadelphia
Bausch Health Site 10, Philadelphia
Bausch Health Site 30, Richmond
Bausch Health Site 06, Richmond
Bausch Health Site 16, Charleston
Bausch Health Site 08, Miami
Bausch Health Site 25, Tupelo
Bausch Health Site 23, Columbus
Bausch Health Site 17, Cincinnati
Bausch Health Site 07, Detroit
Bausch Health 01, Detroit
Bausch Health Site 33, Iowa City
Bausch Health Site 20, Milwaukee
Bausch Health Site 05, Chicago
Bausch Health Site 24, St Louis
Bausch Health Site 22, Dallas
Bausch Health Site 35, Dallas
Bausch Health Site 31, Dallas
Bausch Health Site 02, Houston
Bausch Health Site 37, Houston
Bausch Health Site 15, Los Angeles
Bausch Health Site 19, Los Angeles
Bausch Health Site 18, Corona del Mar
Bausch Health Site 04, San Francisco
Bausch Health Site 21, Seattle
Bausch Health Site 14, Seattle
Bausch Health Site 13, Bristol
Bausch Health Site 03, Boston
Bausch Health Site 27, Newark
Bausch Health Americas, Inc.
INDUSTRY